Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
15 studies found for:    Open Studies | "Aspergillosis"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Aspergillosis"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Exhaled Breath Analysis in the Early Detection of Aspergillosis
Condition: Invasive Aspergillosis
Intervention:
2 Recruiting Bronchoalveolar Lavage Lateral-Flow Device Test for Invasive Pulmonary Aspergillosis: a Multicenter Study
Condition: Invasive Pulmonary Aspergillosis
Intervention: Device: Lateral Flow Device Test
3 Recruiting A Randomized Trial of Itraconazole in Acute Stages of Allergic Bronchopulmonary Aspergillosis
Condition: Allergic Bronchopulmonary Aspergillosis
Interventions: Drug: Itraconazole;   Drug: Glucocorticoids
4 Not yet recruiting PET/CT Guided Antifungal Stewardship in Invasive Pulmonary Aspergillosis
Condition: Aspergillosis and Haematological Malignancy
Interventions: Device: imaging 18F-FDG-PET/CT;   Biological: Blood collection
5 Not yet recruiting An Evaluation of Sequential Computed Tomography of the Chest in Management of Invasive Pulmonal Aspergillosis in Neutropenic Patients With Haematological Malignancies
Condition: Invasive Aspergillosis
Intervention:
6 Not yet recruiting A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of PC945
Condition: Aspergillosis
Interventions: Drug: PC945 - single doses;   Drug: Placebo - single doses;   Drug: PC945 - repeat doses;   Drug: Placebo - repeat doses
7 Not yet recruiting Radiolabelled IV and Oral Metabolism Study of F901318
Condition: Invasive Aspergillosis
Interventions: Drug: IV F901318;   Drug: Oral F901318
8 Not yet recruiting Multiple Ascending Oral Dose Study of F901318 in Healthy Subjects
Condition: Invasive Aspergillosis
Interventions: Drug: F901318 Dose level A oral;   Drug: Placebo dose level A oral;   Drug: F901318 Dose level B oral;   Drug: Placebo dose level B oral;   Drug: F901318 Dose level C oral;   Drug: Placebo Dose level C oral
9 Recruiting Study of Potential for Interaction of Fluconazole With F901318
Condition: Invasive Aspergillosis
Interventions: Drug: F901318;   Drug: Fluconazole
10 Recruiting Concentrations of Voriconazole in Blood and BAL-fluid After Inhalation and Oral Administration
Condition: Invasive Aspergillosis
Intervention: Drug: Voriconazole
11 Recruiting Assessing the Safety and Efficacy of MK-5592 (Posaconazole) in Japanese Participants With Fungal Infection (MK-5592-101)
Condition: Aspergillosis
Interventions: Drug: Posaconazole;   Drug: Voriconazole
12 Recruiting A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069)
Condition: Fungal Infections
Interventions: Drug: Posaconazole;   Drug: Voriconazole
13 Recruiting Lung MRI and Allergic Broncho-pulmonary Aspergillosis in Cystic Fibrosis
Conditions: Pulmonary Cystic Fibrosis;   ABPA
Intervention:
14 Not yet recruiting Study on Safety and Pharmacokinetics of Intravenous F901318 for Fungal Prophylaxis in AML Patients
Conditions: Pulmonary Aspergillosis - Invasive;   Acute Myeloid Leukemia
Interventions: Drug: F901318;   Drug: Caspofungin
15 Not yet recruiting King's Invasive Aspergillosis Study II
Conditions: Aplastic Anemia;   Leukemia, Myeloid, Acute;   Myelodysplastic Syndromes;   Bone Marrow Transplantation
Intervention: Drug: Posaconazole

Study has passed its completion date and status has not been verified in more than two years.